Pathologic Complete Response Rates After Neoadjuvant Pertuzumab and Trastuzumab with Chemotherapy in Early Stage HER2-Positive Breast Cancer - Increasing Rates of Breast Conserving...

Boér Katalin, Kahán Zsuzsanna, Landherr László, Csőszi Tibor, Máhr Károly, Ruzsa Ágnes, Horváth Zsolt, Budai Barna, Rubovszky Gábor
2021